Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
SHPH EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SHPH Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export SHPH earnings history in CSV or JSON format
Free sign-in required to download data
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Earnings Overview
As of May 8, 2026, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported trailing twelve-month net income of -$11M, reflecting -215931.7% year-over-year growth. The company earned $-4.79 per diluted share over the past four quarters.
Looking at the long-term picture, SHPH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$213,594 in fiscal 2017.
Shuttle Pharmaceuticals Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SENS (-$88M net income, -196.0% margin), NVCR (-$173M net income, -20.8% margin), AGEN ($115,000 net income, 0.1% margin), SHPH has comparable earnings metrics. Compare SHPH vs SENS →
SHPH Earnings vs Peers
Earnings metrics vs comparable public companies
SHPH Historical Earnings Data (2017–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$9M | -38.7% | -$8M | $-885.73 | - | - |
| 2023 | -$7M | -32.0% | -$6M | $-0.41 | - | - |
| 2022 | -$5M | -333.6% | -$2M | $-0.30 | - | - |
| 2021 | -$1M | -43.0% | -$2M | $-0.09 | - | - |
| 2020 | $-805,732 | -28.7% | $-509,522 | $-0.07 | - | - |
| 2018 | $-626,139 | -193.1% | $-586,630 | $-0.05 | - | - |
| 2017 | $-213,594 | - | $-203,890 | $-0.02 | - | - |
See SHPH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SHPH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SHPH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSHPH — Frequently Asked Questions
Quick answers to the most common questions about buying SHPH stock.
Is SHPH growing earnings?
SHPH EPS fell to $-4.79, with earnings declining -215931.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-11M.
What are SHPH's profit margins?
Shuttle Pharmaceuticals Holdings, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are SHPH's earnings?
SHPH earnings data spans 2017-2024. The declining earnings trend is -215931.7% YoY. Historical data enables comparison across business cycles.